Verano, Pampilo R.

HRN: 27-41-74  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/05/2025
07/12/2025
IV
300 Mg
Q8
Avulsed Wound
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: